JAMES COLLINS: Open Payments
NPI 1629605159 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$51 in 2 payments from 2 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $51
Food & beverage: $51
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $27 |
| Octapharma USA, Inc. | 1 | $24 |
Products named: INGREZZA, PANZYGA.
Industry payments across CA — which companies pay providers there.
